Humana (HUM) Tops Q1 EPS by $1.26, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Humana Reports First Quarter 2022 Financial Results; Raises Full Year 2022 Adjusted EPS Financial Guidance
April 27, 2022 6:30 AM EDTReports 1Q22 earnings per diluted common share of $7.29 on a GAAP basis, while reporting Adjusted EPS of $8.04 Updates FY 2022 EPS guidance to 'approximately $22.98' on a GAAP basis; raises to 'approximately $24.50' on an Adjusted basis, which continues to contemplate an explicit COVID-19 related headwind of $1.00 per share Reaffirms FY 2022 expected individual Medicare Advantage membership growth range of approximately 150,000 to 200,000
LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per common share for the quarter ended March 31,... More
